scispace - formally typeset
E

Elizabeth S. Nakasone

Researcher at Cold Spring Harbor Laboratory

Publications -  9
Citations -  2101

Elizabeth S. Nakasone is an academic researcher from Cold Spring Harbor Laboratory. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 5, co-authored 5 publications receiving 1719 citations. Previous affiliations of Elizabeth S. Nakasone include Watson School of Biological Sciences.

Papers
More filters
Journal ArticleDOI

Tumors as Organs: Complex Tissues that Interface with the Entire Organism

TL;DR: Understanding the complex ways in which cancer cells interact with their surroundings, both locally in the tumor organ and systemically in the body as a whole, has implications for effective cancer prevention and therapy.
Journal ArticleDOI

Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance

TL;DR: Live imaging of chemotherapy-treated mouse mammary carcinomas allowed us to follow drug distribution, cell death, and tumor-stroma interactions, and associations between vascular leakage and response to doxorubicin, showing that the microenvironment contributes critically to drug response via regulation of vascular permeability and innate immune cell infiltration.
Journal ArticleDOI

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.

Maheen Z. Abidi, +282 more
- 14 Dec 2020 - 
TL;DR: Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments.
Journal ArticleDOI

Live imaging of drug responses in the tumor microenvironment in mouse models of breast cancer

TL;DR: A method for using spinning disk confocal microscopy of live, anesthetized mice to directly observe drug distribution, cancer cell responses and changes in tumor-stroma interactions following administration of systemic therapy in breast cancer models is provided.